NCT02365597 2026-04-13
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
Clinical Trials
11 trialsNCT02946996 2026-03-05
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
Medical University of South Carolina
Phase 2 Terminated
NCT02431676 2024-08-28
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT02420652 2023-02-08
PRIMA
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT02176161 2022-10-18
Metformin Prostate Cancer Adjuvant Trial
NYU Langone Health
Phase 2 Completed
NCT02614859 2022-03-29
BIMET-1
Fox Chase Cancer Center
Phase 2 Completed
NCT02495103 2021-01-26
Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 1/2 Terminated
NCT01620593 2018-05-23
Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed
NCT01433913 2018-01-10
Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT02376166 2017-12-22
M-RePoRT
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT01215032 2017-05-15
Metformin in Castration-Resistant Prostate Cancer
Massachusetts General Hospital
Phase 2 Terminated